EKF Diagnostics (OTCMKTS:EKDHF) Stock Price Up 0.9% – Should You Buy?

EKF Diagnostics Holdings plc (OTCMKTS:EKDHFGet Free Report)’s stock price shot up 0.9% on Tuesday . The company traded as high as $0.3431 and last traded at $0.3431. 20,000 shares were traded during trading, a decline of 6% from the average session volume of 21,293 shares. The stock had previously closed at $0.3402.

EKF Diagnostics Price Performance

The stock’s 50-day moving average is $0.37 and its 200-day moving average is $1,512.68.

EKF Diagnostics Company Profile

(Get Free Report)

EKF Diagnostics Holdings plc (OTCMKTS: EKDHF) is a global in vitro diagnostics company that develops, manufactures and markets a broad range of point-of-care and laboratory analyzers, reagents and consumables. The company’s product portfolio addresses key segments of the diagnostic testing market, including haematology, biochemistry, immunoassay, haemostasis and diabetes monitoring.

EKF Diagnostics offers peripheral blood analyzers designed for use in clinical laboratories, hospitals and veterinary clinics, along with handheld and benchtop devices for rapid on-site testing.

Featured Stories

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.